Mayne Pharma Group Limited Price (MYX.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

79,620,000

(2.0011)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $3.74-7.46
  • Market Cap 586.59M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - General

  • ceo: Mr. Shawn Patrick O'Brien B.Sc
  • IPO Date: June, 29, 2007
  • Country: AU
  • Currency: AUD
  • Headquaters: Salisbury South, SA
  • Employees: 850

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation